AKT1 and prostate carcinoma: This analysis notably highlighted pathways related to prostate cancer, lipid metabolism and atherosclerosis, resistance to EGFR tyrosine kinase inhibitors (TKIs), the PI3K-Akt signaling pathway, chemical carcinogenesis via receptor activation, endocrine resistance, the role of proteoglycans in cancer, pancreatic cancer, acute myeloid leukemia, and infections caused by Kaposi sarcoma-associated herpesvirus.